Teva- Pharmaceutical Industries Ltd. ADR’s recently made public that its See “Remarks” Sabag Mark unloaded Company’s shares for reported $6.1 million on May 08 ’25. In the deal valued at $18.04 per share,337,915 shares were sold. As a result of this transaction, Sabag Mark now holds 150,996 shares worth roughly $2.53 million.
Then, Sabag Mark bought 337,915 shares, generating $6,097,324 in total proceeds.
Before that, Daniell Richard sold 70,961 shares. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $1,128,642 were divested by the Exec. VP, European Commercial at a price of $15.91 per share. As a result of the transaction, Daniell Richard now holds 48,384 shares, worth roughly $0.81 million.
Truist initiated its Teva- Pharmaceutical Industries Ltd. ADR [TEVA] rating to a Buy in a research note published on May 28, 2025; the price target was $25. A number of analysts have revised their coverage, including JP Morgan’s analysts, who increased its forecast for the stock in mid May from “a Neutral” to “an Overweight”. Argus also remained covering TEVA and has increased its forecast on July 10, 2024 with a “Buy” recommendation from previously “Hold” rating. JP Morgan revised its rating on March 08, 2024. It rated TEVA as “a Neutral” which previously was an “an Underweight”.
Price Performance Review of TEVA
On Friday, Teva- Pharmaceutical Industries Ltd. ADR [NYSE:TEVA] saw its stock fall -4.28% to $16.78. Over the last five days, the stock has lost -0.94%. Teva- Pharmaceutical Industries Ltd. ADR shares have fallen nearly -23.87% since the year began. Nevertheless, the stocks have risen 0.12% over the past one year. While a 52-week high of $22.80 was reached on 01/28/25, a 52-week low of $12.47 was recorded on 04/10/25. SMA at 50 days reached $15.64, while 200 days put it at $17.54.
Levels Of Support And Resistance For TEVA Stock
The 24-hour chart illustrates a support level at 16.50, which if violated will result in even more drops to 16.21. On the upside, there is a resistance level at 17.27. A further resistance level may holdings at 17.75. The Relative Strength Index (RSI) on the 14-day chart is 51.37, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.30, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 79.16%. Stochastics %K at 57.81% indicates the stock is a holding.
